A phase I/II study to assess the effect of soluble beta-1,3/1,6-glucan in combination with standard therapy in patients with breast cancer

Update Il y a 4 ans
Reference: EUCTR2006-003620-11

Woman Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Define the clinical toxicity and assess the biologic effects of oral SBG when given to breast cancer patients undergoing standard chemo- and antibody treatment


Inclusion criteria

  • Breast Cancer

Links